Showing 6 results for Habibi
Dr. Aida Moarrefzadeh, Dr. Sadra Sarandili, Dr. Nogol Motamed-Gorji, Dr. Fatemeh Majdolashrafi, Dr. Mansour Bahardoust, Dr. Safa Mousavi, Dr. Neda Hashemi, Dr. Arash Sarveazad, Dr. Mohammadhossein Vazirizadeh-Mahabadi, Dr. Seyed Amirhassan Habibi,
Volume 0, Issue 0 (Accepted Articles 2018)
Abstract
Background: Parkinson's disease (PD) is a common neurodegenerative disease whose motor and non-motor complication greatly affect a person's quality of life (QoL). This study aims to investigate the QoL of these patients using the PDQ-39 questionnaire and identify the prognostic factors associated with their QoL.
Method: In the current case-control study, the QoL of two groups (211 controls and 211 cases) was investigated and compared using the PDQ-39 questionnaire. Prognostic factors associated with QoL were determined using multivariate logistic regression analysis.
Results: A number of 422 patients with the mean age of 59.8 ± 13.7 years were included in the study. The mean score of PDQ-39 in the case group was significantly higher in all subscales except Social support compared to the control group. The mean score of PDQ-39 was significantly higher in the patients with non-DBS (53.9 ± 21.1 (than those with DBS (42.22 ± 18.1(, especially in the sub-scales of Mobility, Activities of daily living, Cognition, and Communication. As the stage of the disease increases, the mean score of PDQ-39 in these patients increases significantly. The results of multivariate analysis showed that gender, patient age, smoking, education level, duration of disease, patient stage, and intervention with DBS were significantly related to patients' QoL (P<0.05).
Conclusion: In conclusion, this study highlights the significant impact of DBS on PD patients' QoL, especially in sub-scales of mobility, daily activities, emotional well-being, and cognition. Moreover, identifying the main prognostic factors in QoL (gender, age, smoking status, educational level, disease duration, and stage) can lead to avenues for improving these patients' lives.
Hassan Ramshini, Azadeh Ebrahim-Habibi, Sima Aryanejad, Abolfazl Rad,
Volume 6, Issue 1 (Winter 2015 -- 2015)
Abstract
Introduction: Diagnosing and treating diseases associated with amyloid fibers remain a great
challenge despite of intensive research carried out. One important approach in the development
of therapeutics is the use of herbal extracts which are rich in aromatic small molecules.
Cinnamomum verum extract (CE) contains proanthocyanidin and cinnamaldehyde, which have
been suggested to be capable of directly inhibiting amyloid fibril formation in vitro. This study
is aimed at characterizing the inhibitory activity of CE against the fibrillation of hen egg white
lysozyme (HEWL).
Methods: Acidic pH and high temperatures were used to drive the protein towards amyloid
formation. Lysozyme was dissolved at 2 mg/mL in 50mM glycine buffer (pH 2.5), and then
incubated at 57 °C for the specified durations while stirred gently by Teflon magnetic bars.
Various techniques including thioflavin T, fluorescence, Congo red absorbance assay and AFM
micrography were used to characterize the HEWL fibrillation processes.
Results: In the absence of CE typical amyloid fibrils (like amyloids formed in Alzheimer disease)
became evident after 48 h of incubation. Upon incubation with various extract concentrations in
the range of 0.1-1 mg/ml, formation of fibrillar assemblies were significantly inhibited (p<0.05).
AFM analysis and MTT assay also confirmed the role of the extract in amyloid inhibition. Our
studies showed that the presence of CE did not have any effect on protein stabilization and thus
directly interact with amyloid structure and inhibit formation of these structures. Furthermore, a
docking experiment showed that a pi-pi interaction may occur between the aromatic component
of cinnamaldehyde and W62. Interestingly, W62 is one of the principal aromatic residues that
interact with glycine amide, which is an aggregation suppressor of HEWL.
Discussion: These observations suggest that aromatic small molecules of CE may directly insert
into amyloidogenic core of early aggregates and inhibit amyloid fibril formation by disrupting
the pi-pi interactions.
Maryam Mehdizadeh, Pablo Martinez-Martin, Seyed Amirhasan Habibi, Negar Nikbakht, Faeze Alvandi, Parvane Bazipoor, Ailin Panahi, Ghorban Taghizadeh,
Volume 10, Issue 4 (July & August 2019)
Abstract
Introduction: In the elderly, functional balance, fear of falling, and independence in daily living activities are interrelated; however, this relationship may change under the influence of drug phase and the severity of disease in individuals with idiopathic Parkinson disease. This study aimed to investigate the association of functional balance, fear of falling, and independence in the Activities of Daily Living (ADL) with the drug on- and drug off-phases.
Methods: A total of 140 patients with Parkinson disease (age: Mean±SD; 60.51±12.32 y) were evaluated in terms of their functional balance, fear of falling, and independence in their daily activities by the Berg Balance Scale (BBS), Fall Efficacy Scale-International (FES-I), and Unified Parkinson Disease Rating Scale-ADL (UPDRS-ADL), respectively, in drug on- and drug off-phases. The Hoehn and Yahr scale recorded global disease rating. The Spearman coefficient, Kruskal-Wallis, and Mann-Whitney tests were used to find out whether the distribution of scale scores differs with regard to functional balance or disease severity.
Results: A strong correlation was found between the functional balance, fear of falling, and independence in ADL with both drug phases. The results also showed the significant difference in the distribution of the FES-I and UPDRS-ADL scores with regard to functional balance (except independence in ADL in drug off-phase). Also, the distribution of the scores of BBS, FES-I, and UPDRS-ADL showed significant differences with regard to disease severity.
Conclusion: The study showed a strong correlation between functional balance, fear of falling, and independence in ADL that can be affected by the drug phase and severity of the disease. However, more studies are needed to understand this relationship precisely.
Ghorban Taghizadeh, Seyed Mohammad Fereshtehnejad, Pablo Martinez-Martin, Mohammad Taghi Joghataei, Fatemeh Mahdizadeh, Sajad Sabbaghi, Sepide Goudarzi, Mahsa Meimandi, Sayed Amir Hasan Habibi, Maryam Mehdizadeh,
Volume 12, Issue 1 (January & February 2021)
Abstract
Introduction: Freezing of gait, a common PD motor symptom, could increase the risk of falling. This study aimed to investigate the clinimetric attributes of the Freezing of Gait Questionnaire (FOGQ) for people with Parkinson disease in the “off” state.
Methods: A total of 115 patients with Parkinson disease (PD; mean age, 60.25 years) were included. Acceptability, internal consistency (by the Cronbach alpha, and test-retest by Intraclass Correlation [ICC]), and reliability of the Persian-translated version of the FOGQ were examined. Dimensionality was estimated by Exploratory Factor Analysis (EFA). Fall efficacy scale-international, unified Parkinson disease rating scale-II, Berg balance scale, functional reach test, and Parkinson disease questionnaire-39 were applied to determine the convergent validity. Diagnostic accuracy for obtaining optimal cutoff point, separating faller and non-faller groups, was analyzed by Receiver Operating Characteristics (ROC) curve analysis and Area Under the Curve (AUC). All tests were carried out in an “off” state.
Results: The Cronbach alpha was high (α=0.92). The test-retest showed high reliability (ICC=0.89). The FOGQ was unidimensional according to the EFA and had acceptable convergent validity with moderate to high correlation with other clinical scales. The optimal cutoff point to discriminate fallers from non-fallers during the “off” state was 9/10, with an AUC of 0.92.
Conclusion: Our results suggest that the FOGQ has appropriate reliability, validity, and discriminative ability for measuring FOG in patients with PD during the “off” state.
Keyvan Olazadeh, Nasrin Borumandnia, Mahin Habibi, Hamid Alavi Majd,
Volume 15, Issue 4 (July & August 2024)
Abstract
Introduction: Traumatic brain injury (TBI) is one of the leading causes of death globally and one of the most important diseases indicated by the World Health Organization (WHO). Several studies have concluded that brain damage can dramatically increase functional connectivity (FC) in the brain. The effects of this hyper-connectivity are not yet fully understood and are being studied by neuroscientists. Accordingly, this study identifies areas of the brain where, after brain injury, an acute increase in FC in such areas is observed.
Methods: The data used in this study were downloaded from the accessible open functional magnetic resonance imaging (fMRI) site. The data included fMRI of 14 patients with severe TBI and 12 healthy individuals. The longitudinal model of variance components investigated the difference between FC in the baseline effect and the longitudinal trend between the TBI and control groups.
Results: After fitting the longitudinal model of variance components, no difference was observed between the FC of the two groups due to the baseline effect. However, in the longitudinal trend of FC, there was a statistically significant difference between the three pairs of cerebellum left, cerebellum right, superior frontal gyrus left, superior frontal gyrus right, thalamus left, and thalamus right in the TBI group compared to the control group.
Conclusion: The results showed that FC was sharply increased in 3 pairs of areas in people with TBI. This hyper-connectivity can affect individuals' cognitive functions, including motor and sensory functions. The exact extent of this effect is unclear and requires further investigation by neuroscientists.
Elahe Habibitabar, Shima Khanverdiloo, Mona Doostizadeh, Leila Jahangard, Jamshid Karimi, Gholamreza Shafiee,
Volume 15, Issue 4 (July & August 2024)
Abstract
Introduction: Major depressive disorder (MDD) is one of the common psychiatric disorders that is characterized by abnormal neurobiological responses. Proprotein convertase subtilisin/kexin 9 (PCSK9) is important in cholesterol homeostasis.
Methods: This study aimed to investigate PCSK9 levels and oxidative stress with MDD disease. The study included 30 patients with MDD and 30 healthy controls. Their blood samples were collected in sterile tubes, and the serum PCSK9 concentration, superoxide dismutase (SOD), and glutathione peroxidase (GPx) activity were determined by ELISA kits. Total antioxidant capacity (TAC), total oxidant status (TOS), malondialdehyde (MDA), and copper concentration were determined manually. There was a significant increase in PCSK9 levels in the patient group (P<0.05).
Results: The receiver operating characteristic (ROC) curve with a sensitivity of 57% and specificity of 52% was 0.928 (95% CI, 0.86-0.996) for PCSK9 in the patient group (P<0.001). It was found that MDA (P=0.036) level was higher in the MDD group, but TAC (P=0.445) level, SOD (P=0.148), GPx (P=0.019) activities, and copper concentration were lower in the patient group compared with the control group.
Conclusion: The study results confirm the relationship between oxidative stress and MDD and also suggest a link between PCSK9 and MDD disease.